Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Fast Is The Oncology Ablation Market Expected to Grow Between 2025 And 2029?

The size of the oncology ablation market has seen a swift increase in recent times. The market is predicted to surge from $1.3 billion in 2024 to $1.46 billion in 2025, boasting a compound annual growth rate (CAGR) of 12.9%. This significant growth during the historical period can be credited to factors like the rising frequency of cancer, an increasing inclination towards less invasive ablation procedures, augmented health care expenditure, the endorsement of new ablation gadgets and technologies, better cancer screening initiatives, and an expanding elderly population.

What Growth Rate Is Anticipated for the Oncology Ablation Market in the Coming Years?

The oncology ablation market is projected to experience significant expansion in the coming years, with a forecasted growth to $2.35 billion by 2029 at a compound annual growth rate of 12.6%. This growth in the forecast period could be linked to the continuous improvements in ablation technology, the escalating adoption of these technologies in developing economies, the expansion of personalized and precision medicine, increased government support and funding for cancer research and innovative treatment methods, a heightened demand for outpatient procedures, and heightened awareness within the public and professional community. Key trends anticipated during the forecast period include the incorporation of artificial intelligence (AI), advancements in imaging technologies, the advent of robotic-assisted ablation, the launch of advanced ablation devices with heightened efficacy, safety, and ease-of-use, and the growing use of telemedicine for pre- and post-ablation care, allowing for remote patient monitoring and follow-ups.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=18415&type=smp

Who Are the Leading Companies in the Oncology Ablation Market?

Major companies operating in the oncology ablation market are Medtronic plc, Siemens Healthineers AG, Becton Dickinson and Company, Koninklijke Philips N.V., Stryker Corporation, GE HealthCare Technologies Inc., Boston Scientific Corporation, Edwards Lifesciences Corporation, Varian Medical Systems Inc, PENTAX Medical, Elekta AB, Merit Medical Systems Inc, AtriCure Inc, AngioDynamics Inc., EDAP TMS S.A., Monteris Medical Inc., Misonix Inc., MedWaves Inc., BSD Medical Corporation, Cardiva Medical Inc.

What Are the Key Drivers of the Oncology Ablation Market?

The escalation in cancer diagnoses is anticipated to fuel the expansion of the oncology ablation market in the future. The term ‘cancer diagnosis’ relates to the identification and affirmation of cancer presence through various medical assessments, imaging procedures, and pathological tissue sample analyses. The upsurge in cancer diagnoses can be attributed to multiple factors, including an aging population, enhancement in screening programs, increased awareness leading to early detection, and environmental influences. Oncology ablation, utilized for treating tumors identified via cancer diagnoses, provides less invasive solutions to eradicate tumors and augment patient results. In May 2024, as reported by the National Cancer Institute – the principal US-based federal government agency responsible for cancer research and training – approximately 2,001,140 fresh cancer cases are anticipated in the United States, with prostate, lung, and colorectal cancers constituting nearly 48% of all diagnoses in males. By 2040, the yearly count of new cancer cases is expected to skyrocket to 29.9 million, underscoring a substantial forthcoming escalation in cancer occurrence. Additionally, in June 2022, as reported by the American Cancer Society – a US-based non-profit organization dedicated to cancer awareness – nearly 1.9 million fresh cancer cases were identified in the US in 2022. Hence, the growing count of cancer diagnoses is set to stimulate the oncology ablation market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=18415&type=smp

What Are the Key Market Segments in the Oncology Ablation Industry?

The oncology ablation market covered in this report is segmented –

1) By Technology: Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation

2) By Treatment: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer

Subsegments:

1) By Radiofrequency Ablation: Monopolar Radiofrequency Ablation, Bipolar Radiofrequency Ablation

2) By Microwave Ablation: Single-Probe Microwave Ablation, Multi-Probe Microwave Ablation

3) By Cryoablation: Cryo-Needle Ablation, Cryo-Generator System Ablation

4) By Irreversible Electroporation Ablation: Transurethral IRE, Transperineal IRE, Percutaneous IRE

What Are the Latest Trends in the Oncology Ablation Market?

Key players in the oncology ablation market are pushing the boundaries through the development of ground-breaking products. These include sophisticated ablation systems bolstered by greater precision, incorporated imaging technologies for real-time guidance, and added safety measures. Advanced ablation systems offering enhanced precision are medical appliances that exploit cutting-edge technology to pinpoint and annihilate abnormal tissue, like tumors, while safeguarding nearby healthy tissue. For example, in March 2024, Medtronic Plc, a medical instrumentation production company headquartered in Ireland, obtained approval for the OsteoCool 2.0 bone tumor ablation system from the US Food and Drug Administration. This system, purpose-built to treat painful bone metastases and benign tumors such as osteoid osteoma, boasts considerable improvements, including the capacity to employ four internally cooled probes at the same time. This permits simultaneous ablation of two vertebral bodies or formation of larger ablation zones in non-spinal applications.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oncology-ablation-global-market-report

What Are the Key Regional Markets in the Oncology Ablation Industry?

North America was the largest region in the oncology ablation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oncology ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18415

This Report Delivers Insight On:

1. How big is the oncology ablation market, and how is it changing globally?

2. Who are the major companies in the oncology ablation market, and how are they performing?

3. What are the key opportunities and risks in the oncology ablation market right now?

4. Which products or customer segments are growing the most in the oncology ablation market?

5. What factors are helping or slowing down the growth of the oncology ablation market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model